Pulmonary arterial hypertension - initial dual therapy authority application form (PB303)
Use this form to apply for initial PBS-subsidised dual therapy PAH treatment.
You can apply for dual therapy PAH treatment with a phosphodiesterase-5 inhibitor with either:
- an endothelin receptor antagonist (ERA)
- a prostanoid.
Download and complete the Pulmonary arterial hypertension - initial dual therapy authority application form.
This PDF is fillable. You can fill it out on your device, or print it and complete it by hand.
You can upload this form in HPOS.
If you have a disability or impairment and use assistive technology, you may not be able to access our forms. If you can’t, please contact us. We can help you access, complete and submit them.
Page last updated: 1 March 2021
This information was printed 10 September 2021 from https://www.servicesaustralia.gov.au/organisations/health-professionals/forms/pb303. It may not include all of the relevant information on this topic. Please consider any relevant site notices at https://www.servicesaustralia.gov.au/individuals/site-notices when using this material.